tm logo
REMEDISC
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 03 Sep 2024

Last Applicant/ Owned by

505 Park Avenue, 14th Floor

New York

NY

10022

Serial Number

97809425 filed on 23rd Feb 2023

Registration Number

N/A

Correspondent Address

Tram Anh Nguyen

Tram Anh Nguyen FARBER LLC

SHELTON, CT 06484

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

REMEDISC

Biomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease.

Classification Information


Class [005]
Pharmaceutical Products


Biomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97809425

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SBP 7005

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Sep 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09th Jul 2024PUBLISHED FOR OPPOSITION
19th Jun 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31st May 2024APPROVED FOR PUB - PRINCIPAL REGISTER
29th May 2024TEAS/EMAIL CORRESPONDENCE ENTERED
28th May 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
28th May 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
28th Feb 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
28th Feb 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED